Clinical Trial

Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this interventional study is to compare the efficacy of clarithromycin Vs levofloxacin based regimen in treatment of Helicobacter pylori infection in patients presenting to medical OPD who are tested positive for H pylori infection.. The main question\[s\] it aims to answer are: • Which regimen is superior in terms of efficacy Participants will be treated for H pylori Infection in with two different regimen If there is a comparison group: Researchers will compare two groups Group 1 will receive clarithromycin based regimen group 2 will receive levofloxacin based regimen to see the treatment response.
Trial Details
NCT Number NCT07021729
Lead Sponsor Rehman Medical Institute - RMI
Conditions Helicobacter Pylori Infection
Enrollment 156 participants
Start Date 2025-12
Primary Completion 2026-03 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-15